News Medical on MSN1d
Glucagon-like peptide-1 receptor agonists may be new treatment for opioid and alcohol use disorder, finds studyOzempic is one of several medications, called glucagon-like peptide-1 receptor agonists or GLP-1 RAs, that are prescribed to ...
Jennifer Linge, PhD https://orcid.org/0000-0001-7399-8375 AMRA Medical AB, Linköping, Sweden (J.L.). Division of Diagnostics and Specialist Medicine, Department of ...
New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people ...
HealthDay on MSN1d
Weight Loss Drugs Like Ozempic, Wegovy May Help Fight Alcoholism and Opioid AddictionA new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds ...
Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...
GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...
Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...
HealthDay on MSN2d
Weight-Loss Meds Like Wegovy Could Battle AlcoholismWeight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more like ...
Ozempic, a popular drug for treating diabetes and promoting weight loss, has emerged as an unexpected weapon in the fight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback